sarpogrelate has been researched along with pravastatin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Heo, TH; Jun, HS; Kwak, MK; Oh, E; Park, KY | 1 |
| Heo, TH; Park, KY | 1 |
2 other study(ies) available for sarpogrelate and pravastatin
| Article | Year |
|---|---|
Pravastatin and Sarpogrelate Synergistically Ameliorate Atherosclerosis in LDLr-Knockout Mice.
Topics: Animals; Atherosclerosis; Cell Proliferation; Cytokines; Drug Synergism; Gene Expression Regulation; Gene Knockout Techniques; Hypolipidemic Agents; Intercellular Adhesion Molecule-1; Lipids; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Monocytes; Myocytes, Smooth Muscle; Plaque, Atherosclerotic; Pravastatin; Receptors, LDL; Succinates | 2016 |
Critical role of TNF inhibition in combination therapy for elderly mice with atherosclerosis.
Topics: Aging; Animals; Atherosclerosis; Cholesterol, Dietary; Cytokines; Diet, High-Fat; Drug Therapy, Combination; Etanercept; Fibrinolytic Agents; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipids; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Plaque, Atherosclerotic; Pravastatin; Receptors, LDL; Succinates; Tumor Necrosis Factor-alpha | 2017 |